Abstract
1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3], the active metabolite of vitamin D3, is a potent inhibitor of breast cancer cell growth both in vivo and in vitro. We have previously demonstrated that 1,25-(OH)2D3 induces morphology (pyknotic nuclei, chromatin and cytoplasmic condensation, and nuclear matrix protein reorganization) consistent with the activation of apoptosis in MCF-7 cells. These morphological changes in 1,25-(OH)2D3-treated cells are associated with up-regulation of TRPM-2/clusterin and cathepsin B (genes associated with mammary gland apoptosis) and down-regulation of bcl-2, an antiapoptotic gene. Thus, the inhibitory effects of 1,25-(OH)2D3 on MCF-7 cell growth involve activation of apoptosis. To investigate the mechanisms by which vitamin D3 activates apoptosis, we have selected a vitamin D3-resistant variant (MCF-7D3Res cells) by continuous culture of MCF-7 cells in 100 nM 1,25-(OH)2D3. The MCF-7D3Res cells represent a stably selected phenotype that grows equally well with or without 100 nM 1,25-(OH)2D3. In contrast to the MCF-7 cells from which they were derived (MCF-7WT cells), MCF-7D3Res cells do not exhibit apoptotic morphology, DNA fragmentation, or up-regulation of apoptosis-related proteins after treatment w...Continue Reading
Citations
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·J X KangA Leaf
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·J X KangR A Chandraratna
Jun 22, 1999·The Journal of Clinical Investigation·C SolomonR Kremer
Aug 27, 2010·Endocrinology·Omar Flores, Kerry L Burnstein
Jan 27, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Belinda Byrne, JoEllen Welsh
Feb 7, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Adebusola A AlagbalaBarbara A Foster
Oct 30, 2009·BMC Genomics·José L CostaBauke Ylstra
Mar 12, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J P BidwellJ Hock
Jul 14, 2001·ANZ Journal of Surgery·J AkhterD L Morris
Dec 10, 1998·British Journal of Pharmacology·S Y JamesK W Colston
Mar 16, 2011·Biochemical and Biophysical Research Communications·Takashi KajitaniTomoki Okazaki
Mar 9, 2010·The Journal of Steroid Biochemistry and Molecular Biology·Bo-Ying BaoYi-Fen Lee
Mar 20, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Joellen Welsh
Aug 6, 2013·IUBMB Life·S Saif HasanImrana Naseem
Feb 16, 1999·The Journal of Laboratory and Clinical Medicine·K YudohT Kimura
Aug 3, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Belinda M Byrne, JoEllen Welsh
Feb 20, 1999·Biology of Reproduction·C AgarwalR L Eckert
Nov 24, 2006·Technology in Cancer Research & Treatment·Shiwu ZhangBaocun Sun
Aug 14, 2001·Journal of Cellular Biochemistry·C M HansenL Binderup
May 1, 1999·Carcinogenesis·A AgadirR Mehta
May 24, 2007·Journal of Cellular Physiology·Edward GarayGeorge P Studzinski
Aug 29, 2007·Acta Pharmacologica Sinica·JoEllen Welsh
Sep 24, 2005·Cell Death and Differentiation·B ShannanJ Reichrath
Nov 5, 1997·Endocrinology·C J Narvaez, J Welsh
Mar 10, 1998·Endocrinology·S H Zhuang, K L Burnstein
Aug 5, 2000·Endocrinology·I M ByrneJ Welsh
Jul 29, 1999·Breast Cancer Research and Treatment·M T Escaleira, M M Brentani
Jan 1, 1997·Breast Cancer Research and Treatment·M Simboli-CampbellJ Welsh
Nov 8, 2000·The Journal of Biological Chemistry·C J Narvaez, J Welsh
Nov 16, 2007·The Journal of Biological Chemistry·Michael MacorittoRichard Kremer
Oct 31, 2017·Endocrinology and Metabolism Clinics of North America·Moray J Campbell, Donald L Trump
Feb 17, 2001·Steroids·C J NarvaezJ Welsh
Jul 2, 1998·Biochemical and Biophysical Research Communications·K OrimotoO Hino